ASCO GU 2023 Conference Coverage
M

Cost-Effectiveness Analysis of Seven Treatment Regimens in mHSPC: A Public Payer Perspective Using Network Meta-Analysis

By ASCO GU 2023 Conference Coverage FEATURING Manish Kohli
By ASCO GU 2023 Conference Coverage FEATURING Manish Kohli
233 views
February 28, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

19:47
Janssen Oncology

All Things PSA

Feat. J. Hamilton, M. Fabrizio, M. Taha

Featured Video

19:22
Janssen Oncology

Doc Talk Podcast

Feat. J. Hamilton, M. Fabrizio, M. Taha

Related Content

AUTOPLAY
Cleveland Clinic Respiratory Institute

Advanced Diagnostic Bronchoscopy Workshop

Fri, Jun 14, 2024
Fox Chase Cancer Center

2024 Atlantic Regional Hematopathology Meeting

Sat, May 11, 2024
Penn Medicine Abramson Cancer Center

Updates in Oncology 2024 Philadelphia: with Proceedings from Interna…

Wed, Jun 12, 2024
UChicago Medicine

27th University of Chicago Comprehensive Cancer Center Developmental…

Fri, May 10, 2024
Vanderbilt University Medical Center (VUMC)

Vanderbilt Stem Cell Transplant and Cellular Therapy Symposium

Sat, May 11, 2024
Yale Cancer Center

Gastrointestinal Cancer CME Series: Gastroesophogeal Cancer

Thu, May 23, 2024
See 1 other
COR2ED The Heart of Medical Education

Precision Oncology in Practice - The Journey from Testing to Treatme…

Tue, Apr 30, 2024
See 1 other
European Research Initiative on CLL - ERIC

ERIC International Meeting 2024 - New Frontiers in CLL Research

Thu, Sep 26, 2024
i3 Health

Live Webinar: Hitting the Target in HER2-Positive Metastatic Colorec…

Mon, Apr 29, 2024
See 2 others
MI&T Congressi

3rd International Summit on Lung Cancer

Sun, May 5, 2024
SOHO Brazil

SOHO Brazil 2024

Thu, May 16, 2024
Total Health

MDONS Metro Denver Chapter Conference

Fri, May 17, 2024
11:56
Ana Aparicio

Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment…

14:16
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Mes…

Feat. E. Efstathiou
16:05
Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini
09:14
Robert Dreicer

AUA Advanced Prostate Cancer Guidelines: 2023 Update

27:04
Fengting Yan

Cancer Screening Molecular Tools

05:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare …

Feat. S. Tagawa
08:05
Total Health

Prostate Cancer Updates From ASCO® 2023

Feat. T. Zhang
11:39
Oncology Data Advisor

Recent Prostate Cancer Updates

Feat. U. Vaishampayan
21:17
Manish Kohli

Time to Castrate Resistance in mCSPC Using Standard of Care Intensif…

19:07
Stanford Medicine

Stanford Medicine Advances in Imaging to Improve Prostate Cancer Dia…

Feat. G. Sonn
09:45
Northwestern Medicine Oncology and Hematology

Differences Between Urologists and Medical Oncologists in the Manage…

Feat. W. Catalona
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
25:33
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute Prostate Cancer Updates From ASCO GU 20…

Feat. J. Berchuck, A. Choudhury
12:39
ASCO GU 2023 Conference Coverage

Efficacy and Safety of Darolutamide in Combination With ADT and Doce…

Feat. C. Sternberg
10:13
Judd Moul

Treatment Intensification in Advanced Prostate Cancer

10:12
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Phase 3 Randomized EMBARK Study - Enzaluta…

Feat. S. Freedland
14:51
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Tailoring Prostate Cancer Care - EMBARK…

Feat. S. Freedland
34:43
OncoAlert

Year in Review: Therapeutic Advances in Prostate Cancer

Feat. N. Agarwal
11:12
E. David Crawford

Phase 3 ARASENS Trial: Overall Safety & Incidences of Adverse Ev…

42:54
Houston Methodist Hospital

30 Years Perspective on Advanced Prostate Cancer: Using Biology &…

Feat. M. Hussain